Results 131 to 140 of about 236,152 (278)

Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations

International Journal of Dermatology, EarlyView.
A panel of 18 dermatologists participated in a three‐round Delphi‐based consensus process to generate a standardized framework for the diagnosis and management of alopecia areata (AA) in Asia Pacific. Recommendations focus on practicality and clinical relevance within the regional context.
Rodney Sinclair, Chao‐Chun Yang, Wen‐Hung Chung, Rachita Dhurat, Anil Ganjoo, Saranya Khunkhet, Jinran Lin, Anchala Parthasaradhi, Hyun‐Tae Shin, Kihyuk Shin, Poonkiat Suchonwanit, Kian Teo Tan, Jyh Jong Tang, Wenyu Wu, Felix Boon‐Bin Yap, Leona Yip, Angeline Yong, Cheng Zhou   +17 more
wiley   +1 more source

Prevalence of Onychomycosis in Patients with Psoriasis: Mycological, Pathological and Dermoscopical Study [PDF]

International Journal of Medical Arts
Background: Onychomycosis, a common nail infection caused by dermatophytes, yeast, and molds, makes up roughly half of all nail conditions worldwide and is the most prevalent nail disorder globally.
Mohamed Mohamed, Hamed Ahmed, Husain Mohamed, Mohamed Mohamed   +3 more
doaj   +1 more source

Nail Psoriasis: A Review of Treatment Options

, 2017
Nail psoriasis is often found in patients with plaque psoriasis and can greatly impact quality of life. This is particularly true in more severe cases, as it affects the structure and function of the patient's nail. Treatment for nail psoriasis is often
Madison Grinnell, Lauren Bonomo, Morgan Rabach   +2 more
core   +1 more source

The Psoriasis–Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric Experience

International Journal of Dermatology, EarlyView.
The psoriasis–atopic dermatitis interface: four clinical phenotypes (coexisting, overlapping, biologic‐induced eczema, dupilumab‐induced psoriasis) across 105 patients from two Italian tertiary centers. JAK inhibitors achieved the highest response rates across all phenotypes, reflecting their mechanistic rationale targeting shared JAK‐STAT downstream ...
Michela D'Agostino, Gennaro Marco Falco, Eleonora De Luca, Clara De Simone, Alessandro Di Stefani, Maddalena Napolitano, Ketty Peris, Matteo Megna, Giacomo Caldarola   +8 more
wiley   +1 more source

Prevalence of onychomycosis among psoriasis patients: a clinico-mycological and dermoscopic comparative cross sectional study

Scientific Reports
Onychomycosis, a nail infection caused by dermatophytes, yeast, and molds makes up roughly half of all onychopathies and is the most prevalent nail condition in the world.
Hamed M. Abdo, Hussein M. Hassab-El-Naby, Mohamed R. Bashtar, Mohamed S. Hasan, Mohamed L. Elsaie   +4 more
doaj   +1 more source

Study of nail changes in psoriasis

, 2018
Background: Psoriasis is a common, chronic and recurrent inflammatory disease of the skin. Clinically, disease can present with cutaneous and nail lesions. Both fingernails and toenails may be affected.Objectives: The present study was conducted to study
Md Zillur Rahman, Md Mostafizur Rahman, Shahanaj Sultana, Md Moksedur Rahman, Md Abdullah, Moriom Nessa, Md Moazzem Hossain, Muhammad Afsar Siddiqui   +7 more
core   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Diagnostic concordance of dermatopathology and PCR in differentiating eczema from psoriasis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Distinguishing psoriasis from eczema is challenging due to overlapping clinical and histological features. This study shows substantial inter‐observer variability among dermatopathologists and demonstrates that a NOS2‐/CCL27‐based molecular test, including a fully automated platform, provides more accurate and reproducible diagnoses, particularly in ...
Andrea Schmitt, Susanne Proksch, Ludwig Gutzweiler, Sandra Roth, Marcella Engler, Cornelia S. L. Müller, Andreas Volz, Andreas W. Arnold, Monika Šedivcová, Adriana Bernklauova, Miroslav Dura, Denisa Kacerovska, Katja Technau‐Ihling, Christian Ihling, Christiane Rakozy, Wiebke Pruessmann, Thomas Leibing, Maria Isabel von Eichborn, Johannes Kern, Elisabeth Oms, Stefanie Eyerich, Kilian Eyerich, Helmut Laaff, Natalie Garzorz‐Stark, Kristin Technau‐Hafsi   +24 more
wiley   +1 more source

Durability of response to icotrokinra for high‐impact site psoriasis: 1‐year ICONIC‐TOTAL findings

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Participants with at least moderate scalp, genital or hand/foot psoriasis receiving once‐daily oral icotrokinra achieved high, durable rates of overall and high‐impact site psoriasis clearance, showed substantial nail psoriasis improvement and exhibited no safety signals through 1 year, supporting icotrokinra use for long‐term management of high‐impact
Richard B. Warren, Melinda Gooderham, Edward Lain, Robert Bissonnette, Yu‐Huei Huang, Julien Ringuet, Matthias Hoffmann, Andreas Pinter, Joseph F. Merola, Jessica H. Rubens, Dorothy Fan, Ming‐Chun Hsu, Shu Li, Ya‐Wen Yang, Cynthia M. C. DeKlotz, Eingun James Song   +15 more
wiley   +1 more source

Nail psoriasis – what a rheumatologist should know about

, 2017
Psoriasis is a chronic recurrent inflammatory skin disease with prevalence of 1–3%. Nail psoriasis affects 10–90% of patients with plaque psoriasis.
Barbara Nieradko-Iwanicka
core   +1 more source